Publications. Pharmacoeconomics Matthijs Versteegh 4/13/26 Pharmacoeconomics Matthijs Versteegh 4/13/26 The Cost Utility of Rhythm Control Treatment Sequences in Patients with Atrial Fibrillation: Anti-arrhythmic Drugs Versus Catheter Ablation Read More Heart Rhythm Matthijs Versteegh 4/13/26 Heart Rhythm Matthijs Versteegh 4/13/26 Antiarrhythmic drugs versus catheter ablation as rhythm control for atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials Read More
Pharmacoeconomics Matthijs Versteegh 4/13/26 Pharmacoeconomics Matthijs Versteegh 4/13/26 The Cost Utility of Rhythm Control Treatment Sequences in Patients with Atrial Fibrillation: Anti-arrhythmic Drugs Versus Catheter Ablation Read More
Heart Rhythm Matthijs Versteegh 4/13/26 Heart Rhythm Matthijs Versteegh 4/13/26 Antiarrhythmic drugs versus catheter ablation as rhythm control for atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials Read More
